These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19372528)

  • 41. [Why are HIV-infected infants still being born in Spain?].
    Fernández-Ibieta M; Ramos Amador JT; Guillén Martín S; González-Tomé MI; Navarro Gómez M; Iglesias González-Nicolás E; Rubio Gribble B; de José Gómez MI; Beceiro Mosquera J; Regidor J; De Santos Butragueño MJ; Martínez Guardia N; Roa Francia MA
    An Pediatr (Barc); 2007 Aug; 67(2):109-15. PubMed ID: 17692255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV prevalence and risk factors in infants born to HIV positive mothers, measured by dried blood spot real-time PCR assay in Tigray, Northern Ethiopia.
    Desta ML; Saravanan M; Hilekiros H; Kahsay AG; Mohamed NF; Gezahegn AA; Lopes BS
    BMC Pediatr; 2019 Jul; 19(1):257. PubMed ID: 31349803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
    Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
    Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
    Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland.
    Etoori D; Kerschberger B; Staderini N; Ndlangamandla M; Nhlabatsi B; Jobanputra K; Mthethwa-Hleza S; Parker LA; Sibanda S; Mabhena E; Pasipamire M; Kabore SM; Rusch B; Jamet C; Ciglenecki I; Teck R
    BMC Public Health; 2018 Mar; 18(1):374. PubMed ID: 29558896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Universal prenatal screening for HIV in Israel--is it justified?].
    Riskin-Mashiah S
    Harefuah; 2014 Jan; 153(1):27-31, 64. PubMed ID: 24605404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnancies Among the First Generation of Survivors of Perinatal HIV Infection.
    Trahan MJ; Boucher M; Renaud C; Karatzios C; Metras ME; Valois S; Ransy DG; Lamarre V; Kakkar F
    J Obstet Gynaecol Can; 2020 Apr; 42(4):446-452. PubMed ID: 31882286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.
    Momplaisir FM; Brady KA; Fekete T; Thompson DR; Diez Roux A; Yehia BR
    PLoS One; 2015; 10(7):e0132262. PubMed ID: 26132142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
    Wade NA; Birkhead GS; Warren BL; Charbonneau TT; French PT; Wang L; Baum JB; Tesoriero JM; Savicki R
    N Engl J Med; 1998 Nov; 339(20):1409-14. PubMed ID: 9811915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.
    Kyaw KWY; Satyanarayana S; Phyo KH; Kyaw NTT; Mon AA; Lwin TT; Aung TK; Oo MM; Aung ZZ; Htun T; Kham NSN; Mya T; Kumar AMV; Oo HN
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):474. PubMed ID: 30514239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
    Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
    Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Timely implementation of interventions to reduce vertical HIV transmission: a successful experience in Brazil].
    Amaral E; Assis-Gomes F; Milanez H; Cecatti JG; Vilela MM; Pinto E Silva JL
    Rev Panam Salud Publica; 2007 Jun; 21(6):357-64. PubMed ID: 17761047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.